Columbus Macro LLC Makes New Investment in iShares Biotechnology ETF $IBB

Columbus Macro LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 10,350 shares of the financial services provider’s stock, valued at approximately $2,179,000.

A number of other hedge funds also recently modified their holdings of the stock. IFP Advisors Inc lifted its holdings in shares of iShares Biotechnology ETF by 39.3% during the 2nd quarter. IFP Advisors Inc now owns 49,988 shares of the financial services provider’s stock worth $9,507,000 after acquiring an additional 14,115 shares during the period. Security National Bank of Sioux City Iowa IA boosted its position in shares of iShares Biotechnology ETF by 31.8% during the 2nd quarter. Security National Bank of Sioux City Iowa IA now owns 12,187 shares of the financial services provider’s stock worth $2,318,000 after acquiring an additional 2,939 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of iShares Biotechnology ETF by 64.0% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 101,838 shares of the financial services provider’s stock worth $19,369,000 after acquiring an additional 39,760 shares in the last quarter. Kestra Advisory Services LLC increased its stake in iShares Biotechnology ETF by 12.2% in the first quarter. Kestra Advisory Services LLC now owns 47,461 shares of the financial services provider’s stock valued at $8,014,000 after acquiring an additional 5,155 shares during the last quarter. Finally, Tidal Investments LLC bought a new position in iShares Biotechnology ETF in the second quarter valued at approximately $1,512,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB traded up $3.23 during mid-day trading on Wednesday, reaching $203.25. The stock had a trading volume of 1,128,899 shares, compared to its average volume of 1,646,237. iShares Biotechnology ETF has a 12 month low of $151.01 and a 12 month high of $217.12. The stock has a 50-day simple moving average of $206.36 and a two-hundred day simple moving average of $187.17.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 18th. Shareholders of record on Tuesday, September 15th were paid a dividend of $0.0112 per share. The ex-dividend date was Tuesday, September 15th. This is a drop from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. This represents a $0.04 annualized dividend and a yield of 0.0%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.